Project Details
Description
A Phase II Study of Ad-RTS-hIL-12 + Veledimex in Combination with Cemiplimab-rwlc (Libtayo??) in Subjects with Recurrent or Progressive Glioblastoma
| Status | Finished |
|---|---|
| Effective start/end date | 7/29/19 → 7/31/24 |
Funding
- ZIOPHARM ONCOLOGY, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.